GWTG-HF Early Follow-Up Trends
follow-up over time and to assess for patient and hospital characteristics associated with early follow-up.
Methods

Data Sources
We used data from the American Heart Association's GWTG-HF registry and fee-for-service Medicare standard analytic claim files for this analysis. The GWTG-HF registry is part of a voluntary, inhospital quality improvement initiative started in 2005, the details of which have been previously published. 9, 10 In brief, patients are eligible for inclusion in the registry if they are hospitalized and HF is the primary discharge diagnosis. Institutions submit information either on consecutive patients or by random sample (a sample is permitted if the institution had >75 cases per year). Clinical data are abstracted in compliance with the Joint Commission on the Accreditation of Healthcare Organizations and Centers for Medicare and Medicaid Services standards.
GWTG-HF collects data on 188 variables, including patient demographics, medical history, in-hospital treatments, and discharge treatments. In February 2009, GWTG-HF specifically added the option for sites to provide information on the date, time, and location of the first scheduled follow-up after hospital discharge. Data are collected with the Internet-based Patient Management Tool (Quintiles Real-World and Late Phase Research, Cambridge, MA).
Institutions participating in GWTG-HF are required to comply with local regulatory and privacy guidelines and to obtain institutional review board approval when necessary. Because the data are used primarily at the local site for quality improvement, sites are granted a waiver of informed consent under the Common Rule. Quintiles (Cambridge, MA) served as the registry coordinating center, and the Duke Clinical Research Institute (Durham, NC) served as the data analysis center. The Institutional Review Board of the Duke University Health System approved this study.
Hospital data elements are collected for all enrolling hospitals from the American Hospital Association database. 11 We also obtained standard analytic files for fee-for-service Medicare beneficiaries from the US centers for Medicare and Medicaid Services. Inpatient files contain institutional claims submitted for facility costs associated with inpatient stays. Outpatient files contain similar institutional claims for outpatient services. Carrier files contain noninstitutional provider and other professional claims for services across all settings. Denominator files include beneficiary identifiers, date of birth, sex, race/ethnicity, date of death (if present), and information about program eligibility and enrollment. We identified registry patients in the Medicare claims data by first linking GWTG-HF registry hospitalizations to Medicare inpatient claims using a previously described process. 12
Study Population and Study Definitions
We evaluated patients enrolled in the GWTG-HF registry between February 1, 2009 and January 31, 2013 who were discharged to home. We excluded patients if there was a medical reason for no follow-up visit or if the discharge date or follow-up visit date seemed invalid or was missing. For example, if the time to scheduled followup was >365 days, then we excluded the patient because of concern for data entry error. We defined early scheduled follow-up as ≤7 days. Other time periods considered were 8 to 14 days and >14 days. These time periods were chosen to be consistent with previous studies. 5 Medicare claim files were available through December 2012. We linked registry patients with fee-for-service Medicare from February 1, 2009 to November 30, 2012 to allow for 1 month of follow-up. We obtained information on Medicare eligibility, enrollment, and death dates from the denominator files, hospital service dates from the inpatient files, and outpatient evaluation and management visits from the outpatient and carrier files. Patients were queried for any actual follow-up (with any provider) on or before the scheduled followup appointment date using Healthcare Common Procedure Coding System, HCPCS codes 992.xx-994.xx. For example, if a patient was scheduled for follow-up at 6 days after discharge and actually followed-up at 8 days then he or she was not considered to have been followed-up within the specified time frame.
Statistical Methods
Patient and hospital characteristics were summarized by time to scheduled follow-up. Continuous variables were reported as medians and 25th and 75th percentiles; categorical variables were reported as counts and percentages. Differences in baseline demographics, medical history, admission laboratory studies and vital signs, hospital characteristics, and outcomes were compared using Pearson χ 2 tests for categorical row variables and Kruskal-Wallis tests for all continuous/ordinal row variables.
Factors independently associated with early scheduled follow-up were identified using multivariable logistic regression with a generalized estimating equation to account for within-hospital clustering. The model assumed an exchangeable working correlation, which assumes nonzero, uniform correlations for all within-subject pairs. Variables included in the adjusted model were age, sex, race, comorbidities (ie, history of ischemia, valvular heart disease, diabetes mellitus, hyperlipidemia, hypertension, chronic kidney disease, smoking, atrial fibrillation or flutter, previous stroke or transient ischemic attack, peripheral arterial disease, anemia, and chronic obstructive pulmonary disease or asthma), admission systolic blood pressure, admission heart rate, left ventricular ejection fraction, prescription of anticoagulants at discharge, teaching hospital, rural hospital setting, geographic region, and number of hospital beds. Single imputation was used to reduce missingness in patient characteristics in the models. All variables included in the model had missing rates of ≤10%. Of note, medical insurance data were not included in the model because of a high missing rate. Missing values for continuous variables were imputed to the median. Missing values for categorical variables were imputed to the most likely category (eg, "no" for comorbidities and discharge medications and the most frequent category for left ventricular ejection fraction). Hospital characteristics were not imputed. Three variables were converted to linear splines: age (single knot at 65 years), admission systolic blood pressure (single knot at 150 mm Hg), and number of hospital beds (single knot at 400 beds). Odds ratios were reported for each piece of the linear spline. P values <0.05 were considered significant. Data were analyzed using SAS version 9.3 (SAS Institute, Cary, NC). 
Results
During the study period, there were 152 899 patients discharged from hospitals participating in the GWTG-HF program. Of these, 42 380 (27.7%) were not discharged home, for example, discharged to a skilled nursing facility, and they were not included in the study; 57 315 (37.5%) were excluded because of invalid or missing follow-up data; 749 (0.49%) were excluded because the patients had a medical reason for no follow-up visit; and 17 (0.01%) were excluded because of a missing hospital discharge date. Characteristics of patients excluded from the analysis are included in Tables I and II in the Data Supplement. The final study population included 52 438 patients from 239 hospitals. Early (≤7 days after discharge) scheduled follow-up improved from 51.1% to 65.7% over time (P<0.001; Figure 1 ). Scheduled follow-up 8 to 14 days after discharge decreased from 27.4% to 20.3%, and scheduled follow-up >14 days after discharge decreased from 21.5% to 14.0% over time. Of the follow-up visits during the study period, 93.7% were scheduled as office visits and 6.3% as home visits.
Patient level factors stratified by scheduled follow-up are listed in Table 1 . Patients with early scheduled followup were more frequently older, had Medicare insurance, and had certain comorbid conditions (eg, pacemaker use, valvular heart disease, hyperlipidemia, chronic kidney disease, atrial fibrillation/flutter, anemia, depression, and preserved left ventricular ejection fraction). Patients with early scheduled follow-up were also more frequently discharged on anticoagulant medications and had scheduled post discharge phone calls. Patients discharged from teaching hospitals and from hospitals in the Northeastern and Western United States were more frequently noted to have early scheduled follow-up. Scheduled follow-up >14 days was more frequent in patients with a previous history of HF, a smoking history, and in those discharged from hospitals in the Southern United States.
Hospital level factors stratified above and below the median rate of early (≤7 days) scheduled follow-up are listed in Table III in the Data Supplement. At a hospital level, the median rate of early follow-up was 60.0% (25th-75th percentile, 47.0-76.5). Hospitals with better performance on the specific quality metric of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use for patients with a left ventricular ejection fraction of <40% at discharge more frequently had rates of early scheduled follow-up above the median. There was no difference in high rates of early follow-up with hospital use of electronic health records or decision support tools. Hospitals with more beds had rates of early scheduled follow-up below the median. Hospitals with the capability to perform bypass surgery also had rates of follow-up below the median; hospitals with only diagnostic catheterization or percutaneous coronary intervention capability had had rates of follow-up above the median.
Patient level factors independently associated with early scheduled (≤7 days) follow-up are listed in Table 2 . After multivariable adjustment, age >65 years was associated with early scheduled follow-up, as were specific comorbid conditions including anemia, diabetes mellitus, and chronic kidney disease not requiring dialysis. Prescription of anticoagulation at discharge was also independently associated with early scheduled follow-up. Patients with a lower admission systolic blood pressure were less likely to have early scheduled follow-up. Patients treated at hospitals located in the Midwestern United States were also less likely to have early scheduled follow-up.
Of the 52 438 patients included in the analysis, 18 730 (35.7%) were linked to fee-for-service Medicare claims data. Of these 18 730 patients, 11 087 (59.2%) were scheduled for early follow-up. Actual early follow-up visits among these patients occurred in 3203 (28.9%) during the study period and improved over time from 26.7% to 30.4% (P=0.005; Figure 2 ). Actual follow-up for ≤7, 8 to 14, and Figure 3 . Few patients without actual follow-up during the scheduled time were because of death or rehospitalization. Most patients had actual follow-up that occurred later than the date scheduled at hospital discharge or no follow-up at all.
Discussion
Previous data suggest that early follow-up after hospital discharge is associated with lower rates of hospital readmission. 5 Our study found that scheduled early follow-up has improved over time, and the vast majority of these visits were scheduled as office visits. Certain patient factors were independently associated with early scheduled follow-up, including older age, comorbidities, and the use of anticoagulation at discharge. Patients discharged from hospitals in the Midwestern United States were less likely to have early follow-up. We found no association with early scheduled follow-up with the use of technologies, such as electronic health records or decision support tools.
With increased use of scheduled follow-up at the time of discharge, we also observed a more modest increase in actual follow within the expected time frame in a substudy of Medicare beneficiaries. A substantial proportion of these patients were still unable to follow-up within the expected time frame with any outpatient provider. This deficiency highlights an important gap in transitional care and a target for further quality improvement efforts. 
GWTG-HF Early Follow-Up Trends
To increase quality and reduce hospital readmissions, the healthcare community is focusing on improving transitions of care, and this study adds to the current understanding of transitional care for patients with HF in the United States. In a previous study using data from 2003 to 2007, the median hospital rate of early follow-up for patients with HF was 38.3%. 5 Since that publication, hospital survey data suggest that 94% of hospitals now prefer patients be seen ≤14 days of discharge, and 40% to 50% of hospitals participating in national quality improvement initiatives have specific strategies to improve early outpatient follow-up. 13, 14 For example, some of the hospitals in our study participated in a specific initiative entitled TARGET: HF, designed to improve performance in key areas of HF care, including early follow-up and care coordination. 15 Our study is the first to examine changes in early scheduled and actual follow-up since the inception of many of these programs.
Certain groups of patients were more likely to have early scheduled follow-up at the time of hospital discharge. Many of the patient characteristics associated with early scheduled follow-up are typical of a vulnerable, higher risk population, for example, older age, diabetes mellitus, impaired renal function, and the use of anticoagulation at discharge. This is in contrast to a previous study of patient characteristics associated with early follow-up using data from 2003 to 2007. 16 In that study, patients with greater comorbidity, including chronic obstructive pulmonary disease and chronic kidney disease, were less likely to have early follow-up. The different findings may be related to changes in practice patterns over time or the fact that the previous study only included patients with fee-for-service Medicare insurance.
Our findings suggest the national focus on early followup, through the publication of evidence supporting its use and the above quality improvement efforts, is translating to greater consideration of early follow-up at the time of discharge. This work at the time of discharge is resulting in meaningful improvements in actual early follow-up over time, although a large proportion of Medicare beneficiaries in our study had lower than expected rates of follow-up within the expected time frame. The reasons for this are not apparent from our data but more work is necessary to understand this important gap in care between scheduled follow-up at discharge and actual follow-up.
Our work also highlights other areas of limited evidence in transitional care. The optimal time period for outpatient follow-up is unknown. Most studies focus on follow-up within 7 or 14 days, 5, 8, 16 although this cutoff is based on observational research and somewhat arbitrary. Defining the appropriate follow-up time has important implications for healthcare resources. Early scheduled follow-up is also only 1 component of the transition of care from the hospital to outpatient setting.
Other key aspects include patient and caregiver education on disease management, early telephone follow up, and timely transmission of care information, such as discharge summaries, to the outpatient care team. Other aspects of transitional care were not analyzed in this study. More studies are needed to create a rigorous evidence base for transitional care, including randomized trials. There is a growing national infrastructure available to conduct efficient, pragmatic, randomized trials of different care interventions, including national registries such as GWTG-HF, 17 the National Institutes of Health Collaboratory, 18 
Limitations
This study has several limitations. First, we limited our analysis to patients in hospitals participating in GWTG-HF, a quality improvement initiative, and these hospitals may be more focused on transitional care than other hospitals. Second, we excluded a high number of patients because of missing data on scheduled follow-up. This was somewhat expected as our study includes data on hospitalizations that occurred previous to the publication of large studies 5 or guidelines 6 supporting this practice. Our results may have differed if we were able to evaluate the years after the 2013 American College of Cardiology Foundation/American Heart Association guideline recommendation for follow-up within 7 to 14 days of hospital discharge. 6 Third, residual measured and unmeasured confounding may affect some of 
Conclusions
Among hospitals participating in GWTG-HF, rates in early scheduled outpatient follow-up for hospitalized patients with HF have improved over time. Actual early follow-up visits also improved over time, but more modestly, and <30% with early follow-up scheduled at discharge had an actual followup visit occur. Important gaps in transitional care remain including actual follow-up after discharge and opportunities remain for improving HF transitional care.
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